Osteo Drug Stops Bone Loss From Breast Cancer Chemo
8/21/2008
HealthDay - THURSDAY, Aug. 21 (HealthDay News) -- The osteoporosis drug Zometa
(zoledronic acid) prevented bone loss at 12 months in premenopausal women
undergoing chemotherapy after they had surgery for early stage breast
cancer, a new study found.
More: - Continued here
Share and enjoy
Post Comment
Entry 1 of 16100
Last Page | Next Page